Your search returned 2 results.

Results
	1.	Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial. MedStar authors: Garcia-Garcia, Hector M Waksman, Ron PMID: 28851504 Year: 2017 Citation: Lancet. 390(10105):1843-1852, 2017 Oct 21. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Bennett J, BIOFLOW V Investigators, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Massaro JM, Mauri L, Roguin A, Waksman R DOI: https://dx.doi.org/10.1016/S0140-6736(17)32249-3 Add to cart (remove)
	2.	Rationale of a novel study design for the BIOFLOW V study, a prospective, randomized multicenter study to assess the safety and efficacy of the Orsiro sirolimus-eluting coronary stent system using a Bayesian approach. MedStar authors: Waksman, Ron PMID: 29129253 Year: 2017 Citation: American Heart Journal. 193:35-45, 2017 Nov Institution: MedStar Heart & Vascular Instituteon Medline publication type: Journal Article Form of publication: Journal Article All authors: Cutlip DE, Doros G, Kandzari DE, Koolen JJ, Massaro JM, Mauri L, Waksman R DOI: https://dx.doi.org/10.1016/j.ahj.2017.08.001 Add to cart (remove)

Refine your search